Summary for Tradename: VIAGRA
Clinical Trials for: VIAGRA
A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions
Status: Completed Condition: Pulmonary Arterial Hypertention
Does Oral Sildenafil (Viagra) Decrease Mean Pulmonary Artery Pressure After Cardiac Surgery?
Status: Recruiting Condition: Pulmonary Hypertension
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet.
Status: Completed Condition: Erectile Dysfunction
Sildenafil (Viagra) Treatment of Subacute Ischemic Stroke
Status: Terminated Condition: Ischemic Stroke
Sildenafil for Prevention of Cerebral Vasospasm
Status: Recruiting Condition: Subarachnoid Hemorrhage; Cerebral Vasospasm; Rupture of Intracranial Aneurysm
Bioequivalence Study For Orally-Disintegrating Tablet Of Sildenafil
Status: Completed Condition: Healthy
A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies
Status: Not yet recruiting Condition: Erectile Dysfunction
Use of Sildenafil (Viagra) in Diabetic Men With Erectile Dysfunction: the Impact on Blood Vessels
Status: Completed Condition: Impotence
Effect of Adding Sildenafil to Protocol of Endometrial Preparation in Outcome of Frozen-thawed Embryo Transfer Cycles
Status: Completed Condition: Endometrial Preparation; Frozen Embryo Transfer
Sildenafil in Single Ventricle Patients
Status: Completed Condition: Heart Disease
Courtesy of ClinicalTrials.org
See more clinical trials for this drug
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Product||Substance||Delist_Flag||Patent Expiration||Exclusivity Expiration|
|TABLET;ORAL||020895||Mar 27, 1998||RX||No||5,250,534*PED||<disabled>||<disabled>|
|TABLET;ORAL||020895||Mar 27, 1998||RX||No||6,469,012*PED||Y||<disabled>||<disabled>|
|TABLET;ORAL||020895||Mar 27, 1998||RX||Yes||5,250,534*PED||<disabled>||<disabled>|
|TABLET;ORAL||020895||Mar 27, 1998||RX||Yes||6,469,012*PED||Y||<disabled>||<disabled>|
|The preview shows a limited data set. Complete access is available with a Subscription|
Export unavailable in trial.
Subscribe for complete access.
|sildenafil citrate||Tablets||25 mg and 50 mg||Viagra||11/19/2004|
|sildenafil citrate||Tablets||100 mg||Viagra||10/25/2004|
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639